AU2003297809A1 - Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes - Google Patents

Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes

Info

Publication number: AU2003297809A1
Authority: AU; Australia
Prior art keywords: compositions; methods; immunodeficiency virus; virus infection; cellular genes
Prior art date: 2002-12-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003297809A

Other versions

AU2003297809A8 (en

Inventor

Stephen J. Dunn

Tanya A. Holzmayer

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

PPD Development LP

Original Assignee

PPD Development LP

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-12-06

Filing date

2003-12-08

Publication date

2004-06-30

2003-12-08 Application filed by PPD Development LP filed Critical PPD Development LP

2004-06-30 Publication of AU2003297809A8 publication Critical patent/AU2003297809A8/en

2004-06-30 Publication of AU2003297809A1 publication Critical patent/AU2003297809A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7153—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for colony-stimulating factors [CSF]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70532—B7 molecules, e.g. CD80, CD86
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/7056—Lectin superfamily, e.g. CD23, CD72
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7158—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for chemokines

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Toxicology (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Cell Biology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU2003297809A 2002-12-06 2003-12-08 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes Abandoned AU2003297809A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US43152202P	2002-12-06	2002-12-06
US60/431,522		2002-12-06
PCT/US2003/039208 WO2004053094A2 (en)	2002-12-06	2003-12-08	Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes

Publications (2)

Publication Number	Publication Date
AU2003297809A8 AU2003297809A8 (en)	2004-06-30
AU2003297809A1 true AU2003297809A1 (en)	2004-06-30

Family

ID=32507745

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003297809A Abandoned AU2003297809A1 (en)	2002-12-06	2003-12-08	Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes

Country Status (2)

Country	Link
AU (1)	AU2003297809A1 (en)
WO (1)	WO2004053094A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2903998B1 (en) *	2006-07-19	2008-09-05	Galderma Res & Dev S N C Snc	MODULATORS OF ELOVL5 IN THE TREATMENT OF ACNE OR HYPERSEBORRHEA
US20120065084A1 (en) *	2009-04-17	2012-03-15	Universite Libre De Bruxelles	Methods and tools for predicting the efficiency of anthracyclines in cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5217889A (en) *	1990-10-19	1993-06-08	Roninson Igor B	Methods and applications for efficient genetic suppressor elements
US5256534A (en) *	1991-08-09	1993-10-26	The United States Of America As Represented By The Department Of Health And Human Services	CD4+, latently HIV-1-infected hematopoietic progenitor cells

2003
- 2003-12-08 AU AU2003297809A patent/AU2003297809A1/en not_active Abandoned
- 2003-12-08 WO PCT/US2003/039208 patent/WO2004053094A2/en not_active Ceased

Also Published As

Publication number	Publication date
WO2004053094A2 (en)	2004-06-24
AU2003297809A8 (en)	2004-06-30
WO2004053094A3 (en)	2004-09-16

Similar Documents

Publication	Publication Date	Title
AU2003279010A1 (en)	2004-04-19	Compositions and methods for delivery of short interfering rna and short hairpin rna
EP1551376A4 (en)	2010-10-06	Immunomodulatory compositions, methods of making, and methods of use thereof
AU2003248862A1 (en)	2004-08-13	Compositions and fabrication methods for hardmetals
AU2003221157A1 (en)	2003-10-08	Method of judging viral infection
AU2003274537A1 (en)	2004-05-04	Pyrrolidine derivatives for use in treating heaptitis c virus infection
AU2002316512A1 (en)	2003-03-03	Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
AU2003229474A1 (en)	2004-11-26	Methods and compositions for detecting sars virus
AU2003227489A1 (en)	2004-11-04	Skin protecting compositions
AU2003213120A1 (en)	2003-09-09	Human rnase iii and compositions and uses thereof
AU2003259202A1 (en)	2004-02-09	Compositions and methods for treating and preventing infection
AU2003300178A1 (en)	2004-07-29	Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
AU2003297809A1 (en)	2004-06-30	Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
IL148225A0 (en)	2002-09-12	Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
IL133159A0 (en)	2001-03-19	Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
AU2002216739A1 (en)	2002-06-11	Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
AU2003275069A1 (en)	2004-04-08	Compositions and methods for preventing infection
AU2003303948A1 (en)	2004-11-23	Compositions and methods for preventing infection
AU2003248853A1 (en)	2004-01-23	Detection of drug-resistant human immunodeficiency virus
AU7114800A (en)	2001-03-26	Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
AU2003257289A1 (en)	2004-02-16	Pharmaceutical compositions for penis enlargement
AU2003214299A1 (en)	2003-07-24	Hiv-1 virus tat-protein mutants
AU2003217579A1 (en)	2003-09-09	Cellular genes regulated by hiv-1 infection and methods of use thereof
AU2002308169A1 (en)	2002-10-15	Compositions and methods for reducing rna virus pathogenicity
WO2005110391A3 (en)	2006-08-31	Compounds for treating human papillomavirus
HK1086009A (en)	2006-09-08	Compositions and methods for viral inhibition

Legal Events

Date	Code	Title	Description
2005-08-25	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase